Cymbalta significantly reduces pain in study patients

Eli Lilly and Co. reported that 31% of 236 patients showed a 50% reduction in chronic lower-back pain after taking once-daily doses of Cymbalta in a study of the depression drug. Only 19% of patients who got placebo reported the same effect, according to the study. The company, which presented the data during a conference in Spain, is seeking FDA approval to market Cymbalta for treating chronic pain. The Wall Street Journal (subscription required) (8/25) , Indianapolis Business Journal (8/25)

http://online.wsj.com/article/SB121966622036968937.html?mod=dist_smartbrief